Application
Gefitinib has been used :
- To study its effective use in endometrial cancer therapy
- Cell proliferation, cell cycle and apoptosis assays
- Cell viability assay and colony formation assay
Biochem/physiol Actions
Gefitinib is a selective epidermal growth factor receptor tyrosine kinase (EGFR TK) inhibitor. Gefitinib has antineoplastic activity, and has been approved for the treatment on non-small cell lung cancer (NSCLC).
Gefitinib has a higher affinity for ATP (adenosine triphosphate) binding site in the EGFR tyrosine kinase domain than ATP. Hence, gefitinib is known to inhibit the progression of endometrial cancer.
- UPC:
- 51201517
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML1657-50MG
- CAS:
- 184475-35-2
akash.verma@cenmed.com
(732) 447-1115





